Pre and Post Menopause
MenaQ7 study show
180 mcg per day of vitamin K2 maintain bone health in postmenopausal women
Well-Being in Times of Change
It is well recognized that women approaching and going through menopause are prone to develop weaker bones.
During this period, hormonal changes lower oestrogen levels, leading to bone loss and increased fracture risk.
Compromised bone health is estimated to affect 200 million women worldwide. Supporting bone health in women during this period of life is growing in importance, particularly as an ageing population seeks to maintain their quality of life.
The combination of Vitamins K2 and D3 is shown to have a more beneficial effect on this demographic’s bone strength than either vitamin taken alone.
MenaQ7® is the only clinically proven K2 to deliver on the promise of maintaining bone health in postmenopausal women.
 Ushiroyama T et al. Maturitas. 202 Mar 25;41(3):211-21.
 Knapen MHJ et al. Osteoporos Int. 2013 Sep;24(9):2499-507.